203 related articles for article (PubMed ID: 16840318)
1. Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells.
Komori K; Hasegawa A; Kurihara K; Honda T; Yokozeki H; Masuda T; Kannagi M
J Virol; 2006 Aug; 80(15):7375-81. PubMed ID: 16840318
[TBL] [Abstract][Full Text] [Related]
2. Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response.
Hasegawa A; Ohashi T; Hanabuchi S; Kato H; Takemura F; Masuda T; Kannagi M
J Virol; 2003 Mar; 77(5):2956-63. PubMed ID: 12584320
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats.
Kato H; Koya Y; Ohashi T; Hanabuchi S; Takemura F; Fujii M; Tsujimoto H; Hasegawa A; Kannagi M
J Virol; 1998 Sep; 72(9):7289-93. PubMed ID: 9696824
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
[TBL] [Abstract][Full Text] [Related]
5. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.
Melamed A; Laydon DJ; Al Khatib H; Rowan AG; Taylor GP; Bangham CR
Retrovirology; 2015 Nov; 12():91. PubMed ID: 26552867
[TBL] [Abstract][Full Text] [Related]
7. Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
Kubota R; Furukawa Y; Izumo S; Usuku K; Osame M
Blood; 2003 Apr; 101(8):3074-81. PubMed ID: 12480698
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor immunity in adult T-cell leukemia].
Kannagi M
Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
[TBL] [Abstract][Full Text] [Related]
9. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.
Koya Y; Ohashi T; Kato H; Hanabuchi S; Tsukahara T; Takemura F; Etoh K; Matsuoka M; Fujii M; Kannagi M
J Virol; 1999 Aug; 73(8):6436-43. PubMed ID: 10400737
[TBL] [Abstract][Full Text] [Related]
12. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
13. Quantification of HTLV-I proviral load in experimentally infected rabbits.
Zhao TM; Hague B; Caudell DL; Simpson RM; Kindt TJ
Retrovirology; 2005 May; 2():34. PubMed ID: 15910683
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
Lee TH; Chafets DM; Busch MP; Murphy EL
J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
[TBL] [Abstract][Full Text] [Related]
15. Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease.
Kannagi M; Ohashi T; Hanabuchi S; Kato H; Koya Y; Hasegawa A; Masuda T; Yoshiki T
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1737-40. PubMed ID: 11080819
[TBL] [Abstract][Full Text] [Related]
16. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
17. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Neuroimmunol; 2000 Jan; 102(2):208-15. PubMed ID: 10636490
[TBL] [Abstract][Full Text] [Related]
19. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load.
Castro-Lima Vargens C; Grassi MF; Boa-Sorte N; Rathsam-Pinheiro RH; Olavarria VN; de Almeida Kruschewsky R; Galvão-Castro B
J Clin Virol; 2011 Nov; 52(3):177-80. PubMed ID: 21868282
[TBL] [Abstract][Full Text] [Related]
20. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; Goon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR
J Immunol; 2004 Oct; 173(8):5121-9. PubMed ID: 15470056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
